Literature DB >> 7647560

Refocusing revisited: an optimized, gradient-enhanced refocused HSQC and its applications in 2D and 3D NMR and in deuterium exchange experiments.

J H Davis1.   

Abstract

2D 15N-1H correlation spectra are ideal for measuring backbone amide populations to determine amide exchange protection factors in studies of protein folding or other structural features. Most protein NMR spectroscopists use HSQC, which has been shown to be generally superior to HMQC in both resolution and sensitivity. The refocused HSQC experiment is intrinsically less sensitive than the regular HSQC, due to T2 relaxation during the refocusing delays. However, we show here that, when high 15N resolution is needed, an optimized refocused HSQC sequence that utilizes a semi-constant time evolution period and pulsed field gradients has better signal-to-noise ratio and resolution, and integrates more accurately, than a similar HSQC. The differences are demonstrated on a 20 kDa protein. The technique can also be applied to 3D NOESY experiments to eliminate strong NH2 geminal peaks and their truncation artefacts at a modest cost in sensitivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647560     DOI: 10.1007/bf00182288

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  12 in total

1.  Structural characterization of folding intermediates in cytochrome c by H-exchange labelling and proton NMR.

Authors:  H Roder; G A Elöve; S W Englander
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

2.  NMR evidence for an early framework intermediate on the folding pathway of ribonuclease A.

Authors:  J B Udgaonkar; R L Baldwin
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

Review 3.  Prospects for NMR of large proteins.

Authors:  G Wagner
Journal:  J Biomol NMR       Date:  1993-07       Impact factor: 2.835

4.  Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a.

Authors:  E R Zuiderweg; S W Fesik
Journal:  Biochemistry       Date:  1989-03-21       Impact factor: 3.162

5.  Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins.

Authors:  S Grzesiek; A Bax
Journal:  J Biomol NMR       Date:  1993-03       Impact factor: 2.835

6.  A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments.

Authors:  T M Logan; E T Olejniczak; R X Xu; S W Fesik
Journal:  J Biomol NMR       Date:  1993-03       Impact factor: 2.835

7.  Effects of DNA binding and metal substitution on the dynamics of the GAL4 DNA-binding domain as studied by amide proton exchange.

Authors:  T Mau; J D Baleja; G Wagner
Journal:  Protein Sci       Date:  1992-11       Impact factor: 6.725

8.  Simultaneous acquisition of [13C,15N]- and [15N,15N]-separated 4D gradient-enhanced NOESY spectra in proteins.

Authors:  B T Farmer; L Mueller
Journal:  J Biomol NMR       Date:  1994-09       Impact factor: 2.835

9.  Mutations Pro----Ala-35 and Tyr----Phe-75 of Rhodobacter capsulatus ferrocytochrome c2 affect protein backbone dynamics: measurements of individual amide proton exchange rate constants by 1H-15N HMQC spectroscopy.

Authors:  P R Gooley; M S Caffrey; M A Cusanovich; N E MacKenzie
Journal:  Biochemistry       Date:  1992-01-21       Impact factor: 3.162

10.  Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments.

Authors:  S R Van Doren; A V Kurochkin; Q Z Ye; L L Johnson; D J Hupe; E R Zuiderweg
Journal:  Biochemistry       Date:  1993-12-07       Impact factor: 3.162

View more
  1 in total

1.  Alterations in chemical shifts and exchange broadening upon peptide boronic acid inhibitor binding to alpha-lytic protease.

Authors:  J H Davis; D A Agard; T M Handel; V J Basus
Journal:  J Biomol NMR       Date:  1997-07       Impact factor: 2.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.